Serum nitric oxide levels are depleted in depressed patients treated with electroconvulsive therapy
- PMID: 34789933
- PMCID: PMC8522622
- DOI: 10.4103/indianjpsychiatry.indianjpsychiatry_1441_20
Serum nitric oxide levels are depleted in depressed patients treated with electroconvulsive therapy
Abstract
Background: Nitric oxide (NO) is an endogenous substance which has several endocrine functions and may act as neurotransmitter in the brain. High levels of NO may provoke nitrosative stress.
Aim: It was aimed to examine serum levels of NO in patients with depressive episodes who were treated with electroconvulsive therapy (ECT) in this study.
Methods: The design was a case-control, follow-up study. Patients with depressive episodes (n = 23) and a healthy control group (n = 21) were enrolled. Three serum samples were obtained from the patient group (before ECT, after first and seventh sessions). NO, nitrite, and nitrate levels were examined.
Statistical analysis: Differences between groups were examined with t-test or Mann-Whitney U-test. Longitudinal data were evaluated with Panel Regression Analysis and Kruskal-Wallis Test.
Results: Serum levels of NO and nitrite decreased significantly after the seventh session of ECT administration compared to the baseline and first session. Nitrate levels did not differ between the assessments.
Conclusions: Reduction of the serum NO and nitrite levels might be a contributing factor for hypertension during the sessions. These findings are reflect the circulating NO levels. Further studies may dissect NO physiology in the brain in mental disorders and potential external effects.
Keywords: Depressive disorder; electroconvulsive therapy; nitric oxide.
Copyright: © 2021 Indian Journal of Psychiatry.
Conflict of interest statement
There are no conflicts of interest.
Figures
Similar articles
-
Effects of electroconvulsive therapy on nitrosative stress and oxidative DNA damage parameters in patients with a depressive episode.Int J Psychiatry Clin Pract. 2022 Sep;26(3):259-268. doi: 10.1080/13651501.2021.2019788. Epub 2022 Jan 24. Int J Psychiatry Clin Pract. 2022. PMID: 35073501
-
Blood serum concentrations of kynurenic acid in patients diagnosed with recurrent depressive disorder, depression in bipolar disorder, and schizoaffective disorder treated with electroconvulsive therapy.Psychiatr Pol. 2017 Jun 18;51(3):455-468. doi: 10.12740/PP/61584. Epub 2017 Jun 18. Psychiatr Pol. 2017. PMID: 28866716 English, Polish.
-
Electroconvulsive Therapy and Extracellular Matrix Glycoproteins in Patients with Depressive Episodes.Psychiatry Clin Psychopharmacol. 2021 Jun 1;31(2):157-164. doi: 10.5152/pcp.2021.20161. eCollection 2021 Jun. Psychiatry Clin Psychopharmacol. 2021. PMID: 38765234 Free PMC article.
-
Cytokines changes associated with electroconvulsive therapy in patients with treatment-resistant depression: a Meta-analysis.Psychiatry Res. 2021 Mar;297:113735. doi: 10.1016/j.psychres.2021.113735. Epub 2021 Jan 16. Psychiatry Res. 2021. PMID: 33497973 Review.
-
Brain-derived neurotrophic factor blood levels after electroconvulsive therapy in patients with major depressive disorder: A systematic review and meta-analysis.Asian J Psychiatr. 2020 Jun;51:101983. doi: 10.1016/j.ajp.2020.101983. Epub 2020 Feb 26. Asian J Psychiatr. 2020. PMID: 32146142
Cited by
-
Flavonols in Action: Targeting Oxidative Stress and Neuroinflammation in Major Depressive Disorder.Int J Mol Sci. 2023 Apr 7;24(8):6888. doi: 10.3390/ijms24086888. Int J Mol Sci. 2023. PMID: 37108052 Free PMC article. Review.
-
A Systematic Review of the Literature Regarding the Relationship Between Oxidative Stress and Electroconvulsive Therapy.Alpha Psychiatry. 2022 Mar 1;23(2):47-56. doi: 10.5152/alphapsychiatry.2021.21584. eCollection 2022 Mar. Alpha Psychiatry. 2022. PMID: 36426296 Free PMC article. Review.
-
Does the Use of Rocuronium-Sugammadex Instead of Succinylcholine in Electroconvulsive Therapy Affect Seizure Duration?Psychiatry Investig. 2022 Oct;19(10):824-831. doi: 10.30773/pi.2022.0123. Epub 2022 Oct 21. Psychiatry Investig. 2022. PMID: 36327962 Free PMC article.
-
Altered serum glutathione disulfide levels in acute relapsed schizophrenia are associated with clinical symptoms and response to electroconvulsive therapy.BMC Psychiatry. 2025 Mar 14;25(1):242. doi: 10.1186/s12888-025-06691-w. BMC Psychiatry. 2025. PMID: 40087601 Free PMC article.
References
-
- Iancu SC, Wong YM, Rhebergen D, van Balkom AJ, Batelaan NM. Long-term disability in major depressive disorder: A 6-year follow-up study. Psychol Med. 2020;50:1644–52. - PubMed
-
- Malhi GS, Outhred T, Morris G, Boyce PM, Bryant R, Fitzgerald PB, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders: Bipolar disorder summary. Med J Aust. 2018;208:219–25. - PubMed
-
- Canbek O, Menges OO, Atagun MI, Kutlar MT, Kurt E. Report on 3 years’ experience in electroconvulsive therapy in Bakirkoy Research and Training Hospital for psychiatric and neurological diseases: 2008-2010. J ECT. 2013;29:51–7. - PubMed
-
- Canbek O, Yuksel G, Atagun MI, Ipekcıoglu D, Kurt E, Menges OO, et al. Geriatric ECT at a Turkish Teaching Hospital: A 5-year experience. J ECT. 2014;30:e28–9. - PubMed
-
- Tørring N, Sanghani SN, Petrides G, Kellner CH, Østergaard SD. The mortality rate of electroconvulsive therapy: A systematic review and pooled analysis. Acta Psychiatr Scand. 2017;135:388–97. - PubMed
LinkOut - more resources
Full Text Sources